Mannitol, Viaflo Baxter

Mannitol, the active ingredient in Viaflo Baxter, is an osmotic diuretic presented as a solution for injection for intravenous use. It reduces intracranial pressure, promotes diuresis in acute renal failure, and lowers intraocular pressure in glaucoma patients.

GNH USA supplies Viaflo Baxter as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Mannitol is employed as an osmotic diuretic in several clinical situations that require rapid fluid shift.

- Intracranial hypertension: reduces intracranial pressure by drawing water from brain tissue into the vascular compartment. - Acute renal failure: promotes diuresis to facilitate renal clearance of waste products. - Glaucoma: lowers intraocular pressure by osmotic dehydration of the vitreous humor. - Intraocular pressure elevation: decreases pressure within the eye, aiding in the management of ocular hypertension.

Mannitol may be associated with a range of adverse reactions, varying from mild to severe.

Common Side Effects: - Headache: mild to moderate intensity. - Nausea and vomiting: gastrointestinal upset following infusion. - Thirst or dry mouth: due to osmotic effect. - Electrolyte disturbances: mild hyponatremia or hypernatremia. - Transient hypotension: drop in blood pressure during rapid infusion. - Tachycardia: increased heart rate secondary to volume shifts.

Serious or Rare Side Effects: - Pulmonary edema: fluid accumulation in lungs. - Severe electrolyte imbalance: marked hypernatremia or hypokalemia. - Acute renal failure worsening: reduced kidney function. - Anaphylactic reaction: rare hypersensitivity. - Hemolysis: destruction of red blood cells. - Hyperosmolar coma: extreme plasma osmolality.

When using Mannitol, clinicians should observe several precautionary measures to minimize risk.

- Renal function: assess baseline renal performance and avoid use in anuric patients. - Electrolytes: monitor serum sodium, potassium and osmolality before and during therapy. - Cardiac status: use cautiously in patients with heart failure or volume overload. - Fluid balance: avoid excessive infusion rates that may cause circulatory overload. - Pregnancy: consider only if potential benefit justifies potential risk, as safety data are limited. - Store at ambient temperature: keep in original container, protect from light and moisture.

Mannitol can interact with other medicines, influencing their efficacy or safety.

Major Interactions (Avoid): - Loop diuretics: additive diuretic effect may cause profound electrolyte loss. - Insulin: hyperosmolar state can impair glucose control. - Nephrotoxic agents: increased risk of renal injury when combined.

Moderate Interactions (Monitor Closely): - ACE inhibitors or ARBs: monitor blood pressure and renal function for additive effects. - Antihypertensive drugs: potential for enhanced hypotension. - Lithium: altered renal clearance may raise lithium levels.